| 236 |
2026-02-24 |
PT. NOVELL PHARMACEUTICAL LABORATORIES |
Lft.01.141 | Leaflet Eterlox (01) |
3,400 |
exp |
On Progress |
|
| 235 |
2026-02-24 |
PT. NOVELL PHARMACEUTICAL LABORATORIES |
LFT.02.078 | LFT Phenytoin Sodium Inj |
3,300 |
exp |
On Progress |
|
| 234 |
2026-02-24 |
PT. NOVELL PHARMACEUTICAL LABORATORIES |
LFT/03/979 | LFT Ondavell ODT (03) |
4,500 |
exp |
On Progress |
|
| 233 |
2026-02-24 |
PT. NOVELL PHARMACEUTICAL LABORATORIES |
LFT/00/1241 | LFT Fosfomycin DI |
4,500 |
exp |
On Progress |
|
| 232 |
2026-02-24 |
PT. NOVELL PHARMACEUTICAL LABORATORIES |
LFT/00/1212 | LFT Noveron Inj Exp Vietnam |
4,500 |
exp |
On Progress |
|
| 231 |
2026-02-24 |
PT. NOVELL PHARMACEUTICAL LABORATORIES |
Lft/01/654 | LFT Butavell Inj Vietnam (01) |
14,800 |
exp |
On Progress |
|
| 230 |
2026-02-24 |
PT. NOVELL PHARMACEUTICAL LABORATORIES |
LFT/01/962 | LFT Voxib |
3,300 |
exp |
On Progress |
|
| 229 |
2026-02-23 |
PT. NOVELL PHARMACEUTICAL LABORATORIES |
PartVel | Partisi UB Velutine SI |
45,500 |
exp |
On Progress |
|
| 228 |
2026-02-23 |
PT. NOVELL PHARMACEUTICAL LABORATORIES |
Lft/02/398 | LFT Ataroc (02) |
3,300 |
exp |
On Progress |
|
| 227 |
2026-02-23 |
PT. NOVELL PHARMACEUTICAL LABORATORIES |
LFT/00/1182 | LFT Vosera |
37,200 |
exp |
On Progress |
|